| Autor: |
Christian Jacobi, Peter Paul Urban, Sebastian Jander |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
Neurology International Open. 2:E84-E92 |
| ISSN: |
2511-1795 |
| Popis: |
A wide range of established treatment options is currently available for myasthenia gravis. These include cholinesterase inhibitors for symptomatic treatment and a broad spectrum of immunosuppressive, immunomodulating or cell-depleting options to modify the underlying immunological process. Appropriate use allows the great majority of patients to lead a normal life. Specialized centers integrating outpatient and in-hospital resources as well as interdisciplinary competences offer important advantages for optimum individualized therapy. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
